XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Total Share-Based Compensation Expense
Total share-based compensation expense was as follows:
Three Months Ended
March 31,
20232022
(In thousands)
Stock option expense$3,584 $3,440 
Restricted stock expense5,040 4,778 
Performance restricted stock unit expense1,655 1,353 
Total pre-tax expense$10,279 $9,571 
Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the periods indicated:
Three Months Ended
March 31, 2023
Year Ended December 31, 2022
Expected volatility26.0 %24.5 %
Expected term (years)5.05.0
Risk-free interest rate3.54 %2.33 %
Expected dividend yield0.72 %0.65 %
Black-Scholes-Merton fair value per stock option granted$38.11 $32.54 
Summary of Stock Option Activity and Related Information
The following is a summary of the Company’s stock option activity and related information:
SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life 
Aggregate
Intrinsic
Value
(In thousands)(Years)(In millions)
Outstanding at December 31, 20223,060 $79.46 
Granted453 138.46 
Exercised(188)63.07 
Forfeited(25)117.84 
Outstanding at March 31, 20233,300 $97.70 7.0$157.2 
Exercisable at March 31, 20232,336 $82.51 6.0$146.7 
Summary of Nonvested Restricted Stock Activity and Related Information
The following is a summary of the Company’s non-vested restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested restricted stock outstanding at December 31, 2022356 $117.18 
Granted152 138.48 
Vested(154)103.97 
Forfeited(10)120.35 
Non-vested restricted stock outstanding at March 31, 2023344 $132.42 
The following is a summary of the Company’s non-vested performance restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested performance restricted stock outstanding at December 31, 2022275 $101.98 
Granted79 138.46 
Performance assumption change 1
48 63.37 
Vested(161)63.37 
Forfeited  
Non-vested performance restricted stock outstanding at March 31, 2023241 $131.90 
_________________________________________
1 Reflects the number of PRSUs above target levels based on performance metrics.